CIK 0000926617
- Non-accelerated filer
- Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330595156
- Phone
- +1 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Grant or award Director acquired 54,825 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 114,218 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Executive Chair bought 43,994 shares at $0.57 ($24,918)
- 4 Open-market buy President and CEO bought 98,000 shares at $0.76 ($74,892)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 73,656 shares (grant or award)
- 4 Grant or award Director acquired 99,671 shares (grant or award)
- 4 Grant or award Director acquired 72,937 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 23,033 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 330 shares (grant or award)
- 4 Grant or award Director acquired 423 shares (grant or award)
- 4 Grant or award Director acquired 15,902 shares (grant or award)
- 4 Grant or award Director acquired 14,728 shares (grant or award)
Page 9 of 28 · 551 filings